tiprankstipranks
Trending News
More News >
Advertisement

FNY - ETF AI Analysis

Compare

Top Page

FNY

First Trust Mid Cap Growth AlphaDEX Fund (FNY)

Rating:68Neutral
Price Target:
$102.00
The ETF FNY, representing the First Trust Mid Cap Growth AlphaDEX Fund, has a solid overall rating, suggesting a balanced mix of strengths and challenges among its holdings. Notable contributors to its rating include NEXTracker (NXT), which benefits from strong financial performance, reasonable valuation, and market leadership, and Coeur Mining (CDE), which demonstrates robust production, cost management, and strategic debt reduction. However, weaker holdings like Rigetti Computing (RGTI), with declining revenues and negative profit margins, and AST SpaceMobile (ASTS), facing financial and operational challenges, may have weighed on the fund's overall score. A key risk factor is the potential overvaluation of several holdings, which could impact future performance.
Positive Factors
Strong Top Holdings
Several of the largest positions, such as MP Materials and Bloom Energy, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Industrials, Technology, and Health Care, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The fund has shown solid growth so far this year, which may appeal to investors seeking momentum.
Negative Factors
High Geographic Concentration
With nearly all assets invested in U.S. companies, the ETF lacks exposure to international markets, limiting diversification.
Relatively High Expense Ratio
The ETF charges a higher expense ratio compared to many similar funds, which could eat into investor returns over time.
Underperforming Holding
SoundHound AI, one of the top holdings, has shown negative year-to-date performance, slightly dragging on the fund’s overall results.

FNY vs. SPDR S&P 500 ETF (SPY)

FNY Summary

The First Trust Mid Cap Growth AlphaDEX Fund (FNY) is an ETF that focuses on mid-sized companies in the U.S. with strong growth potential. It follows the NASDAQ AlphaDEX Mid Cap Growth Index, using a unique strategy to pick stocks based on growth factors. The fund includes companies like Bloom Energy and Symbotic, and covers sectors such as technology, healthcare, and industrials. Investors might consider FNY for its potential to deliver growth and diversify their portfolios with mid-cap stocks. However, it’s important to note that the ETF’s performance can fluctuate with market conditions, and its focus on mid-cap growth companies may make it more volatile than broader market funds.
How much will it cost me?The expense ratio for the First Trust Mid Cap Growth AlphaDEX Fund (FNY) is 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because the fund is actively managed, using a specialized methodology to select and weight stocks for potential growth. Active management typically involves higher costs compared to passively managed funds that track an index.
What would affect this ETF?The First Trust Mid Cap Growth AlphaDEX Fund (FNY) could benefit from positive trends in the U.S. economy, such as technological advancements and increased demand for industrial and healthcare innovations, given its strong exposure to these sectors. However, it may face challenges from rising interest rates, which can negatively impact growth-focused companies, and potential economic slowdowns that could reduce consumer spending and affect cyclical sectors. Regulatory changes or geopolitical tensions could also influence the performance of its top holdings in industries like energy and materials.

FNY Top 10 Holdings

The First Trust Mid Cap Growth AlphaDEX Fund (FNY) is leaning heavily into mid-cap growth, with a strong focus on industrials and technology, sectors that make up nearly half of its portfolio. Bloom Energy is rising steadily, buoyed by strategic developments and earnings momentum, while MP Materials is showing promise with solid technical momentum and partnerships. On the flip side, Rigetti Computing is lagging, weighed down by weak financials despite some bullish technical signals. With its U.S.-centric exposure and sector concentration, the fund is positioned for growth but faces mixed performance among its top holdings.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Bloom Energy1.13%$5.22M$31.26B1229.58%
67
Neutral
Symbotic1.09%$5.01M$47.80B184.63%
70
Outperform
Guardant Health1.08%$4.97M$11.72B304.43%
54
Neutral
NEXTracker, Inc. Class A0.99%$4.57M$15.02B155.54%
80
Outperform
AST SpaceMobile0.95%$4.37M$29.17B236.48%
54
Neutral
Ciena0.94%$4.35M$26.79B196.89%
70
Outperform
Lumentum Holdings0.90%$4.14M$14.29B208.43%
54
Neutral
Rigetti Computing0.86%$3.97M$14.35B3499.19%
49
Neutral
TTM Technologies0.85%$3.89M$6.94B204.21%
71
Outperform
Wayfair0.84%$3.87M$13.49B157.81%
57
Neutral

FNY Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
91.09
Positive
100DMA
87.09
Positive
200DMA
82.56
Positive
Market Momentum
MACD
0.66
Positive
RSI
52.66
Neutral
STOCH
58.99
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FNY, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 92.97, equal to the 50-day MA of 91.09, and equal to the 200-day MA of 82.56, indicating a bullish trend. The MACD of 0.66 indicates Positive momentum. The RSI at 52.66 is Neutral, neither overbought nor oversold. The STOCH value of 58.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FNY.

FNY Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$463.64M0.70%
68
Neutral
$863.74M0.06%
70
Outperform
$410.19M0.31%
70
Neutral
$297.70M0.35%
71
Outperform
$155.67M0.85%
68
Neutral
$128.92M0.60%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FNY
First Trust Mid Cap Growth AlphaDEX Fund
93.04
13.38
16.80%
IMCV
iShares Morningstar Mid-Cap ETF
NUMG
Nuveen ESG Mid-Cap Growth ETF
RFG
Invesco S&P Midcap 400 Pure Growth ETF
TMFM
Motley Fool Mid-Cap Growth ETF
FRTY
Alger Mid Cap 40 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement